Waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Pursuant to the provisions of H. Res. 677, H. Res. 659 is laid on the table.
(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Waives a specified requirement of Rule XIII (Calendar and Committee Reports) to allow consideration of a bill (amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, and to enhance the postmarket authorities of the Food and Drug Administration (FDA) with respect to the safety of drugs) on the same day it is presented to the House.
- Reported in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H. Res. 659: Waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules.. 110th Congress. Open America. https://openamerica.io/bill/110-HRES-659/
"H. Res. 659: Waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules.." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HRES-659/.
H. Res. 659, 110th Cong. (2026), https://openamerica.io/bill/110-HRES-659/.
[H. Res. 659: Waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules.](https://openamerica.io/bill/110-HRES-659/)